Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.
about
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationIntravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysisSYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB.When important steps for a reliable meta-analysis are missing: the bevacizumab versus ranibizumab case.
P2860
Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparison of bevacizumab and ...... atic review and meta-analysis.
@ast
Comparison of bevacizumab and ...... atic review and meta-analysis.
@en
type
label
Comparison of bevacizumab and ...... atic review and meta-analysis.
@ast
Comparison of bevacizumab and ...... atic review and meta-analysis.
@en
prefLabel
Comparison of bevacizumab and ...... atic review and meta-analysis.
@ast
Comparison of bevacizumab and ...... atic review and meta-analysis.
@en
P2093
P2860
P1476
Comparison of bevacizumab and ...... atic review and meta-analysis.
@en
P2093
Cao-Yu Sun
Jing-Na He
Shao-Dan Zhang
Xiao-Fan Guo
Xiao-Yu Zhang
P2860
P304
P356
10.3980/J.ISSN.2222-3959.2014.02.30
P577
2014-04-18T00:00:00Z